The Liver Meeting by AASLD serves as the premier global forum for hepatology, bringing together leading researchers, clinicians, and industry experts to share breakthroughs in liver disease and drug discovery. The event highlights cutting-edge translational science, novel therapeutic targets, and advances in evaluating liver safety and pathology. Javelin will be attending to showcase how our human in vitro liver platforms generate high-translatability data sets to better predict liver PKPD and toxicity and accelerate liver disease research.